SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-036217
Filing Date
2023-11-02
Accepted
2023-11-02 08:01:00
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q itci-20230930.htm   iXBRL 10-Q 840984
2 EX-31.1 itci-20230930xex311.htm EX-31.1 9633
3 EX-31.2 itci-20230930xex312.htm EX-31.2 9650
4 EX-32 itci-20230930xex32.htm EX-32 5439
  Complete submission text file 0001628280-23-036217.txt   4459711

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20230930.xsd EX-101.SCH 28568
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20230930_cal.xml EX-101.CAL 53715
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20230930_def.xml EX-101.DEF 129696
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20230930_lab.xml EX-101.LAB 492129
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20230930_pre.xml EX-101.PRE 296285
51 EXTRACTED XBRL INSTANCE DOCUMENT itci-20230930_htm.xml XML 517116
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 231370159
SIC: 2834 Pharmaceutical Preparations